U.S. Oil and Gas Stock News

Cohen & Steers (CNS) has just posted its Q2 2026 numbers, with total revenue of US$152.7 million and basic EPS of US$0.96, while trailing twelve month revenue sits at US$583.9 million and EPS at US$3.28. Over recent quarters, revenue has moved from US$134.5 million in Q1 2025 to US$145.6 million in Q1 2026 and then US$152.7 million in Q2 2026, with quarterly EPS ranging from US$0.68 in Q4 2025 to US$0.82 in Q1 2026 and US$0.96 in the latest quarter. This sets up a results season in which...

Great Southern Bancorp (GSBC) opened Q2 2026 with total revenue of US$56.9 million and basic EPS of US$1.45, alongside trailing twelve month revenue of US$226.8 million and EPS of about US$6.06 that frame the latest quarterly print. Over recent periods the company has seen revenue move from US$224.3 million to US$229.2 million and then to US$226.8 million on a trailing basis, while TTM EPS has shifted from roughly US$5.88 to US$6.23 and then to US$6.06. This gives investors a clear view of...

Lululemon athletica (NasdaqGS:LULU) has invested in French nylon recycling startup Syntetica, aiming to integrate recycled materials into future product lines. The company has also opened a large automated distribution center in North America, focused on e-commerce fulfillment and regional logistics. Both moves reflect Lululemon's focus on supply chain sustainability and operational efficiency in its core athletic apparel business. Lululemon athletica has grown from a yoga-focused apparel...

Home BancShares (HOMB) has reported Q2 2026 results with total revenue of US$289.9 million and basic EPS of US$0.59, alongside net income excluding extra items of US$119.3 million. Over the past year, the company has seen total revenue move from US$260.1 million in Q1 2025 to US$289.9 million in Q2 2026, while quarterly EPS has ranged from US$0.58 to roughly US$0.63. Trailing twelve month EPS now stands at about US$2.42. With a net interest margin at 4.51% and a cost to income ratio just...

Cushman & Wakefield (NYSE:CWK) has released new sector reports highlighting a turning point across several real estate segments. The company points to strengthening U.S. apartment and industrial markets, resilient U.S. retail vacancy trends, and rising contractor confidence in Asia Pacific offices. These updates reflect shifting fundamentals following recent market challenges across core property sectors. Cushman & Wakefield, trading at around $14.05, sits at the center of these changing...

Johnson & Johnson (JNJ) just posted Q2 2026 revenue of US$25.3 billion and basic EPS of US$2.27, with trailing 12 month EPS at US$8.70 and net income of US$21.0 billion framing the latest quarter against a much larger earnings base. Over recent quarters the company has seen revenue move from US$23.7 billion in Q2 2025 through a range of roughly US$24.0 billion to US$24.6 billion, while quarterly EPS has tracked between US$2.10 and US$2.30 outside of a one off spike in early 2025. This sets a...

Greif stock has delivered a 54.1% return over the past 5 years, yet its current valuation screens as somewhat rich on market multiples and only middling on the broader checks. This raises the question of how much optimism is already in the price. A 54.1% 5 year return suggests Greif has rewarded patient shareholders, so investors now need to judge whether that strength is already reflected in the share price. Expectations around Greif's ability to sustain cash generation from its packaging...

GDS Holdings (NasdaqGM:GDS) is being highlighted as a key potential beneficiary of China's multi year national data center build out tied to accelerating AI adoption. The profile focuses on GDS's role within government backed digital infrastructure plans that prioritize high performance computing capacity for AI workloads. This policy driven push is presented as a material shift for data center operators positioned to support AI and cloud growth in China. GDS Holdings operates large scale...

Why this leadership shake up at MBX Biosciences matters for investors MBX Biosciences (MBX) is in focus after the board promoted Executive Chairman Steve Hoerter to Chief Executive Officer and Chairman, while confirming John Smither as Chief Financial Officer, reshaping the company’s senior leadership team. See our latest analysis for MBX Biosciences. The leadership changes at MBX Biosciences arrive after a sharp run up in momentum, with the stock showing a 45.47% 1 month share price return...

Baidu announces a reported AI partnership with Apple focused on integrating its generative AI capabilities. The company also confirms a voluntary move to a dual-primary listing on the Hong Kong Stock Exchange. Both developments come as Baidu's NasdaqGS:BIDU shares last closed at $112.82. Baidu is back in focus after it reported a new AI partnership with Apple and outlined plans to convert to a dual-primary listing in Hong Kong. The stock, NasdaqGS:BIDU, has fallen 24.9% year to date but is...

Stubborn import price pressure and talk of higher for longer rates are putting U.S. industrial and technology equipment stocks under a sharper spotlight, especially those tied to machinery, computers, and semiconductors. With Chinese import costs climbing and AI related hardware getting more expensive, some companies could see margins squeezed while others may find room to improve pricing power. This article explains how the latest data may affect a selection of large equipment manufacturers...

On 7 July 2026, Apollo Commercial Real Estate Finance, Inc. (NYSE: ARI) was removed from both the S&P TMI Index and the S&P Global BMI Index, reducing its presence in widely followed equity benchmarks. This dual index removal matters because it can alter how index-tracking funds and benchmark-aware investors engage with ARI, potentially affecting trading patterns and liquidity. Next, we’ll examine how ARI’s removal from key S&P indices might influence its existing investment narrative and...

Trevi Therapeutics stock has delivered a very large 5 year return, yet the current valuation checks lean expensive rather than cheap, which raises the question of how much of that strength is already reflected in the price. Over the past 5 years, Trevi Therapeutics has returned about 7.6x, which sets a high bar for any further upside to be justified by fundamentals. Future progress in turning its drug pipeline into consistent revenue can support the current share price. The risk is that...

Emerson Electric (NYSE:EMR) introduced new refinery automation solutions that integrate crude scheduling and product blending into its Aspen Unified Scheduling platform. The launch targets margin critical refinery workflows, aiming to reduce manual interventions and support faster responses to market volatility. Emerson Electric, trading at $139.08, is adding another software layer around its automation hardware with this refinery focused rollout. The stock is up 59.9% over the past 3 years...

In the last week, the United States market has stayed flat, yet it has risen by 19% over the past year with earnings forecasted to grow by 18% annually. In such a climate, identifying stocks that are potentially undervalued can be an effective strategy for investors seeking opportunities that may offer significant upside relative to their intrinsic value.

Over the last 7 days, the United States market has remained flat, yet it has shown impressive growth of 19% over the past year with earnings expected to increase by 18% annually. In this environment, identifying growth companies with significant insider ownership can be particularly appealing as it often signals confidence in a company's potential and alignment of interests between management and shareholders.

The United States market remained flat over the last week, but it is up 19% over the past year, with earnings forecast to grow by 18% annually. The term 'penny stocks' might feel like a relic of past market eras, but the potential they represent is as real as ever. Typically referring to smaller or relatively new companies, these stocks can provide a mix of affordability and growth potential when paired with strong financials.

NANO Nuclear Energy stock has fallen 57% over the past year, yet the current valuation checks do not clearly flag it as a bargain. This sets up a tension between the weak share price performance and what the numbers say about value. Over the last 12 months, the share price is down 57%, which means recent investors have faced steep losses even before considering whether the stock now looks cheap or still expensive. Broader investor interest in nuclear energy, highlighted by recent buying in...

After a 122.5% total return over the past 5 years, Johnson Controls International now faces a tougher question on price. Its Discounted Cash Flow (DCF) intrinsic value estimate points to the shares trading at a premium, while market based multiples look closer to fair. Over 5 years, the stock has returned 122.5%, which puts current buyers in a very different position from those who entered earlier in the run. Recognition such as the recent IDEA innovation award and growing interest in HVAC...

Winmark (WINA) has put fresh numbers on the table for Q2 2026, with total revenue of US$22.0 million and basic EPS of US$2.90, supported by trailing twelve month revenue of US$86.5 million and EPS of US$11.42 that sit alongside a 47.1% net margin, slightly below 49.5% a year earlier. Over recent quarters the company has seen revenue move within a tight band between US$20.4 million and US$22.6 million per quarter, while quarterly EPS has ranged from about US$2.59 to US$3.13. This backdrop...

Heilind Electronics recently announced the availability of Brady Corporation’s i4311 Industrial Label Printer, the first portable model combining a swappable all-day battery, ergonomic carrying handle, and the ability to print labels up to 4.25 inches wide. This hybrid of benchtop performance and cordless mobility highlights Brady’s push to serve industrial users who need high-capability identification tools in the field as well as at the workstation. We’ll now examine how the i4311’s...

Extreme Networks stock has delivered a very strong 194.9% return over the past five years, and today the valuation picture shows a company that still screens as undervalued on both intrinsic value estimates and market multiples, but with only a mixed score when all checks are considered together. Over five years, Extreme Networks is up 194.9%, which puts recent pullbacks in a longer trend of substantial value creation for shareholders. Growing demand for data center networking equipment...

After a 134.0% total return over the past 5 years, HBT Financial now trades at US$33.39. The central question is whether that performance is fully reflected in the price when set against its intrinsic value estimate and broader valuation checks. A 134.0% 5 year return indicates that long term shareholders in HBT Financial have already seen substantial value created, so any new position needs a clear view on remaining upside. The Excess Returns model suggests the intrinsic value sits...

Maze Therapeutics stock has delivered a strong 59.2% return over the past year, yet its low value score and an overvalued read on market multiples suggest investors are paying up without a clear margin of safety. Over the last 12 months, Maze Therapeutics has returned 59.2%, which puts the spotlight on whether recent gains already reflect much of the good news investors expect. Future progress in turning its pipeline into consistent, scalable cash flows can support the current share price,...